Reliq Health Technologies Inc V.RHT.H

RE:RE:Silent shareholder

[qwerty22]

"Adherence is something big to watch.  Both should be covered in the upcoming update."

Problem is the last update threw out numbers (clients adherence rate 20%, reliq adherence rate 70%) which on the surface look like a good fix but there is insufficient detail there to know exactly what that means for the company (or short term revenue growth to be precise). Presumably they performed something akin to an experiment. They took a certain number of patients, had Reliq work a new process and got better adherence at the end. There is no promise within that outcome that they would then be able to roll out that process to the vast number of patients already under contract. For example we have no idea how many patients per mon5h they can process in this new way. That will determine how quickly they can convert individuals to revenue generator. If the number they can process is quite low then you eff3ctively still have a bottleneck around adherence until you can put in plac3 the resourses to more rapidly produce adherence. It's an assumption I've made in the past that this fix they have recen5 signalled will rapidly spread across the whole patient base but that could easily be a false assumption.

I guess the problem is we haven't the info to know adherence has been fixed in a scalable way yet. I guess I'm not expecting enough info at the next update to fully answer that but lets see.

theinvestor22 wrote: Thank you for posting.  Some folks here are upset with the progress of the company, some think they were "promised" great rewards which haven't materialized and others are apparently at war with the share count.  There's at least one person here who thinks all these counterparties are signing up with Reliq because they aren't obligated to onboard anyone.  Go figure.

Like you, I tend to give greater weight to actual progress as opposed to predictions/estimates.  In this case,  SaaS revenue is moving ahead nicely and device revenue (a predictor of future SaaS revenue) is doing very well.  Lot's of SNF contracts have been signed, which again should be a precursor to a lot of very collectable one time and recurring revenue.  Bigger contracts too.

In terms of collections, I've mentioned before that I think this won't be an issue going forward, but it is subject to verification.  Adherence is something big to watch.  Both should be covered in the upcoming update.

Now, on to your points.  I don't think the company or its CEO are incompetent.  Their strategy might be different than amateur investors would want, but it's clearly working.

In terms of a sale of the company, I've no idea when that would happen.  Cognizant is probably the most likely candidate, but it could be years off.  Most fast growing companies would want to see more revenue development in order to maximize the sale price, so I wouldn't expect anything soon.  But, who really knows?

You might be more egalitarian than I am when it comes to dealing with negative posters.  I'm happy to read dissenting opinions (with rationale), but constant repetition of the same thing, being stuck in 2018, bitterness and cynicism don't offer me anything useful, so I just use the ignore button.  Your choice...

Regards...i22

Efnjesuschrist wrote: First time posting and I'll try not to make this a habit. It seems obvious that there is a disconnect between what some are saying and what the company is doing. If the reliq haters are correct, why is there so much confidence in Lisa from the industry? If Lisa or the company was incompetent, wouldn't the contracts dry up? They aren't, and if no mention of the Nasdaq in July, probably no intention of listing on it and most likely the company sells to cognizant for 40 times revenues. Any thoughts? If your comment is negative, please provide evidence with your opinions.